Zhaoke Ophthalmology Ltd. (HK:6622) has released an update.
Zhaoke Ophthalmology Ltd. has released its unaudited consolidated interim financial results, reporting a reduction in losses for the first half of 2024 compared to the same period in 2023. Despite an increase in revenue and other income, the company faced significant R&D expenses, although these were lower than the previous year. The overall financial performance shows a mixed picture, with losses narrowing but still present.
For further insights into HK:6622 stock, check out TipRanks’ Stock Analysis page.
